Pennsylvania lawmakers eye 'biosimilar' approvals

By The Associated Press | Posted - Jun. 24, 2014 at 4:51 p.m.

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

HARRISBURG, Pa. (AP) — Pennsylvania state senators passed legislation to require physician approval before dispensing alternatives to patented biological medicines over the protests of insurance companies and pharmacists.

The Senate voted 44-6 for the bill. It is supported by the Biotechnology Industry Organization, which represents major pharmaceutical makers. The sponsor, Sen. Pat Vance, called it a patient safety bill.

It would require a pharmacist to notify the prescribing physician before dispensing what is called a biosimilar medication.

Drugmakers say the notification is essential because biosimilars aren't identical to the biological medication they'd replace.

But the Insurance Federation of Pennsylvania and Pennsylvania Pharmacists Association say the extra steps would undermine the use and development of biosimilars, which are less expensive than brand-name drugs.

The U.S. Food and Drug Administration hasn't approved any biosimilar medications yet.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

The Associated Press


    Catch up on the top news and features from, sent weekly.
    By subscribing, you acknowledge and agree to's Terms of Use and Privacy Policy.

    KSL Weather Forecast